A method for preparing cyclododecene and a synthesis device therefor, of the present invention, remarkably increase the conversion ratio of cyclododecatriene and selectivity of cyclododecene, can minimize the costs required for equipment and processing, are practical, reduce processing time, and are industrially advantageous to mass production in comparison with a conventional method and device.

A method for preparing cyclododecene and a synthesis device therefor, of the present invention, remarkably increase the conversion ratio of cyclododecatriene and selectivity of cyclododecene, can minimize the costs required for equipment and processing, are practical, reduce processing time, and are industrially advantageous to mass production in comparison with a conventional method and device.

The invention relates to a method for producing cyclododecanone (CDON). During the production, contaminated cyclododecane (CDAN) is produced. This can be separated from CDON by distillation (CDAN-containing fraction). The separation of CDAN and impurities such as 13-oxabicyclo [7.3.1]tridecane occurs by crystallizing out CDAN from the CDAN-containing fraction.

The invention relates to a method for producing cyclododecanone (CDON). During the production, contaminated cyclododecane (CDAN) is produced. This can be separated from CDON by distillation (CDAN-containing fraction). The separation of CDAN and impurities such as 13-oxabicyclo [7.3.1]tridecane occurs by crystallizing out CDAN from the CDAN-containing fraction.

Disclosed herein are embodiments of nanohoop compounds, methods of making, and methods of using the same. The nanohoop compounds disclosed herein have discrete ring system(s) that comprise a unique meta-substituted motif that affords a strained cavity in which myriad reaction chemistries can take place. The unique structures and properties of the nanohoop compounds disclosed herein also lend to their use in a variety of biological applications, and as interlocked structures in molecular machines.

Disclosed herein are embodiments of nanohoop compounds, methods of making, and methods of using the same. The nanohoop compounds disclosed herein have discrete ring system(s) that comprise a unique meta-substituted motif that affords a strained cavity in which myriad reaction chemistries can take place. The unique structures and properties of the nanohoop compounds disclosed herein also lend to their use in a variety of biological applications, and as interlocked structures in molecular machines.

A method for preparing cyclododecene and a synthesis device therefor, of the present invention, remarkably increase the conversion ratio of cyclododecatriene and selectivity of cyclododecene, can minimize the costs required for equipment and processing, are practical, reduce processing time, and are industrially advantageous to mass production in comparison with a conventional method and device.

A method for preparing cyclododecene and a synthesis device therefor, of the present invention, remarkably increase the conversion ratio of cyclododecatriene and selectivity of cyclododecene, can minimize the costs required for equipment and processing, are practical, reduce processing time, and are industrially advantageous to mass production in comparison with a conventional method and device.

Disclosed herein are embodiments of nanohoop compounds, methods of making, and methods of using the same. The nanohoop compounds disclosed herein have discrete ring system(s) that comprise a unique meta-substituted motif that affords a strained cavity in which myriad reaction chemistries can take place. The unique structures and properties of the nanohoop compounds disclosed herein also lend to their use in a variety of biological applications, and as interlocked structures in molecular machines.

The invention relates to a method for producing cyclododecanone (CDON). During the production, contaminated cyclododecane (CDAN) is produced. This can be separated from CDON by distillation (CDAN-containing fraction). The separation of CDAN and impurities such as 13-oxabicyclo [7.3.1]tridacane occurs by crystallizing out CDAN from the CDAN-containing fraction.